11.40
-1.95
(-14.61%)
At close: January 24 at 4:00:01 PM EST
9.35
-2.05
(-17.98%)
Pre-Market: 7:05:13 AM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 125,248 | 27 |
| Sales | 1,800 | 1 |
| Net Shares Purchased (Sold) | 123,448 | 28 |
| Total Insider Shares Held | 165.49k | -- |
| % Net Shares Purchased (Sold) | 293.60% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| PRIDGEN WILLIAM L Director | Purchase at price 1.30 per share. | Indirect | 19,992 | Aug 21, 2023 |
| DUNCAN GREGORY SCOTT Chief Executive Officer | Purchase at price 1.25 per share. | Direct | 31,245 | Aug 17, 2023 |
| WHITLEY RICHARD JAMES Director | Sale at price 0.26 per share. | Direct | 466 | Dec 8, 2022 |
| DUNCAN GREGORY SCOTT Chief Executive Officer | Purchase at price 4.52 per share. | Direct | 33,900 | May 23, 2022 |
| WALSH ANGELA Officer | Purchase at price 4.58 per share. | Indirect | 9,150 | May 23, 2022 |
| WHITLEY RICHARD JAMES Director | Purchase at price 4.53 per share. | Direct | 2,262 | May 18, 2022 |
| PRIDGEN WILLIAM L Director | Purchase at price 4.50 per share. | Indirect | 1,084 | May 18, 2022 |
| PRIDGEN WILLIAM L Director | Purchase at price 4.38 per share. | Indirect | 58,914 | May 17, 2022 |
| PRIDGEN WILLIAM L Director | Purchase at price 4.94 per share. | Indirect | 2,964 | Mar 29, 2022 |
| PRIDGEN WILLIAM L Director | Purchase at price 5.46 per share. | Indirect | 12,002 | Mar 23, 2022 |
| PRIDGEN WILLIAM L Director | Purchase at price 5.98 per share. | Indirect | 24,998 | Jan 27, 2022 |
| DE LA ROSA ABEL Director | Purchase at price 5.90 per share. | Direct | 23,584 | Jan 7, 2022 |
| WHITLEY RICHARD JAMES Director | Purchase at price 5.72 per share. | Direct | 10,296 | Jan 6, 2022 |
| THOMAS JOHN C JR Unknown | Purchase at price 5.65 per share. | Direct | 5,650 | Jan 4, 2022 |
| KEEFER DAVID R Director | Purchase at price 5.79 per share. | Direct | 28,975 | Jan 4, 2022 |
| PRIDGEN WILLIAM L Director | Purchase at price 5.43 per share. | Indirect | 12,034 | Jan 3, 2022 |
| WHITLEY RICHARD JAMES Director | Purchase at price 5.72 per share. | Direct | 1,145 | Dec 23, 2021 |
| DUNCAN GREGORY SCOTT Chief Executive Officer | Purchase at price 5.52 per share. | Direct | 27,615 | Dec 21, 2021 |
| PRIDGEN WILLIAM L Director | Purchase at price 5.66 per share. | Indirect | 49,997 | Dec 21, 2021 |
| PRIDGEN WILLIAM L Director | Purchase at price 6.32 per share. | Direct | 5,951 | Jul 7, 2021 |
| DUNCAN GREGORY SCOTT Chief Executive Officer | Purchase at price 6.36 per share. | Direct | 2,429 | Apr 6, 2021 |
| DUNCAN GREGORY SCOTT Chief Executive Officer | Purchase at price 6.17 per share. | Direct | 96,757 | Apr 5, 2021 |
| DUNCAN GREGORY SCOTT Chief Executive Officer | Purchase at price 6.17 per share. | Direct | 96,757 | Apr 5, 2021 |
| PRIDGEN WILLIAM L Director | Purchase at price 7.47 per share. | Indirect | 26,145 | Jan 29, 2021 |
| PRIDGEN WILLIAM L Director | Conversion of Exercise of derivative security at price 7.80 per share. | Direct | 6,248 | Jan 28, 2021 |
| WALSH ANGELA Officer | Purchase at price 7.30 per share. | Indirect | 7,300 | Jan 28, 2021 |
| KEEFER DAVID R Director | Conversion of Exercise of derivative security at price 7.80 per share. | Indirect | 12,496 | Jan 28, 2021 |
| DUNCAN GREGORY SCOTT Chief Executive Officer | Conversion of Exercise of derivative security at price 7.80 per share. | Direct | 6,248 | Jan 6, 2021 |
| PRIDGEN WILLIAM L Director | Purchase at price 11.98 per share. | Direct | 17,970 | Dec 17, 2020 |
Related Tickers
EVAX Evaxion Biotech A/S
6.03
+65.66%
RNAZ TransCode Therapeutics, Inc.
7.04
+28.00%
TNXP Tonix Pharmaceuticals Holding Corp.
0.3831
+16.98%
IPA ImmunoPrecise Antibodies Ltd.
0.5765
-3.92%
HEPA Hepion Pharmaceuticals, Inc.
0.1906
-4.70%
ELAB PMGC Holdings Inc.
3.1000
+56.57%
MRNA Moderna, Inc.
41.41
-2.31%
MGX Metagenomi, Inc.
2.9700
0.00%
RXRX Recursion Pharmaceuticals, Inc.
7.33
-2.66%
NEUP Neuphoria Therapeutics Inc.
4.3900
+25.79%